Literature DB >> 28291674

[Trigeminal neuralgia secondary to petrous endostosis].

Jacinto Mata-Gómez1, Manuel Royano-Sánchez2, Macarena Bejarano-Parra3, Ignacio Gilete-Tejero2, María Rico-Cotelo2, Marta Ortega-Martínez2.   

Abstract

Arterial neurovascular compression is hypothesised to be the main cause of primary trigeminal neuralgia. Although it is the most common cause, other pathologies, such as tumours in the cerebellopontine angle, can cause trigeminal pain. We report a case of a 44-year-old female patient with right trigeminal neuralgia without satisfactory response to medical treatment. Cerebral MRI showed no structural injuries. During microvascular decompression of the trigeminal nerve, endostosis of the internal aspect of the petrous bone was found to compress the trigeminal nerve. The pain disappeared completely in the early postsurgical period, after the complete drilling of the endostosis and microvascular decompression. The patient remains asymptomatic one year later. Endostosis of the petrous bone is a rare cause of trigeminal neuralgia. A proper review of preoperative studies would enable the definitive surgical approach to be optimised.
Copyright © 2017 Sociedad Española de Neurocirugía. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Abordaje retrosigmoideo; Cerebellopontine angle; Descompresión microvascular; Endostosis petrosa; Microvascular decompression; Neuralgia del trigémino; Petrous endostosis; Retrosigmoid approach; Trigeminal neuralgia; Ángulo pontocerebeloso

Mesh:

Year:  2017        PMID: 28291674     DOI: 10.1016/j.neucir.2017.01.004

Source DB:  PubMed          Journal:  Neurocirugia (Astur)        ISSN: 1130-1473            Impact factor:   0.553


  1 in total

1.  Case report of unusual cause of trigeminal neuralgia: Trigeminal neuralgia secondary to enlarged suprameatal tubercle.

Authors:  Bilal Ibrahim; Baha'eddin A Muhsen; Edinson Najera; Hamid Borghei-Razavi; Badih Adada
Journal:  Ann Med Surg (Lond)       Date:  2021-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.